中鋼協:3月鋼鐵生產庫存按月「雙降」
中國鋼鐵工業協會統計顯示,3月份重點鋼鐵企業日產量按月下降,整體庫存有所降低但仍處於較高水平。
生產方面,3月份重點統計鋼鐵企業累計平均日產生鐵、粗鋼、鋼材分別為182.4萬噸、169.5萬噸、176.6萬噸,按月分別下降2.1%、3.1%和1.7%。
企業庫存方面,3月下旬重點統計鋼鐵企業鋼材庫存量為1,806.7萬噸,較3月上旬的最高庫存量減少334.2萬噸,降幅15.6%;較年初增加853.4萬噸,增幅89.5%。
社會庫存方面,3月下旬統計的20個城市5大品種鋼材社會庫存為1,906萬噸,較3月上旬的最高庫存量減少115萬噸,降幅5.7%;較年初增加1094萬噸,增幅134.7%。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.